Avant Diagnostics Commences OvaDx Ovarian Cancer Test Calibration in Preparation for FDA Submission

By: via Benzinga
Avant Diagnostics, Inc. (OTC: AVDX) began calibration testing in preparation for the validation study of OvaDx®, which will be used to ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.